Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Brian McNabb"'
Autor:
Felicia Cosman, Tiffany Y. Kim, Dennis M. Black, Brian McNabb, Richard Eastell, Douglas C. Bauer, Anne L. Schafer
Publikováno v:
Journal of Bone and Mineral Research. 34:810-816
An ASBMR Task Force recommends a drug holiday for certain women treated for ≥5 years with oral alendronate or ≥3 years with intravenous zoledronic acid, with reassessment 2 to 3 years later. It is not known whether changes in bone mineral density
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170b9dd4885075a74afed01b5982716d
https://doi.org/10.1002/jbmr.3654
https://doi.org/10.1002/jbmr.3654
Autor:
Diana M. Brainard, Brian McNabb, Yasuhito Tanaka, Hidenori Toyoda, John G. McHutchison, Kazuaki Chayama, Tatsuya Ide, Gregory Camus, Yoshiyuki Ueno, Satoru Kakizaki, Koichi Takaguchi, Masashi Mizokami, Deyuan Jiang, Satoshi Mochida, Fusao Ikeda, Masayuki Kurosaki, Hirayuki Enomoto, Hiroshi Yatsuhashi, Tetsuo Takehara, Namiki Izumi, Yoshiiku Kawakami, Shampa De-Oertel, Luisa M. Stamm
Publikováno v:
Hepatology International
Background/purpose In Japan, there is a growing population of patients with chronic hepatitis C virus (HCV) infection who failed a direct-acting antiviral (DAA)-based regimen. In this Phase 3 study, we evaluated sofosbuvir–velpatasvir plus ribaviri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7dbb95d2d83b6786e884edfef6685a2
https://doi.org/10.1007/s12072-018-9878-6
https://doi.org/10.1007/s12072-018-9878-6
Autor:
Jun Cheng, Hong Tang, Lai Wei, Qin Ning, Shanming Wu, Jin Lin Hou, Gregory Camus, Diana M. Brainard, Qing Xie, Brian McNabb, Jidong Jia, Yuemin Nan, Peng Hu, Guozhong Gong, Guiqiang Wang, Jianning Jiang, Fangqiu Zhang, Zhuangbo Mou, Jun Li, Zhongping Duan, Anu Osinusi, Yanhang Gao, Lunli Zhang, Hongmei Mo
Publikováno v:
Hepatology International
Background Chronic hepatitis C virus (HCV) infection is a significant medical burden in China, affecting more than 10 million persons. In clinical trials and real-world settings, treatment with ledipasvir/sofosbuvir in patients with genotype 1 HCV in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31bf2cddb23e441b93b874b2aa0f116c
http://europepmc.org/articles/PMC5904238
http://europepmc.org/articles/PMC5904238
Autor:
Xavier Forns, Luis Enrique Morano Amado, Antonio Rivero, Juan A. Pineda, Rosa Maria Morillas, José A. Carrión, Luisa M. Stamm, Gregory Camus, Manuel J. Rodriguez, Sabela Lens, Raúl J. Andrade, Gulan Zhang, G. Mani Subramanian, Mar Riveiro-Barciela, Juan Turnes, Jose Luis Calleja, Rafael Esteban, Diana M. Brainard, Brian McNabb, Juan Manuel Pascasio Acevedo, Marta Casado, Maria Buti
Background & Aims In phase 3 trials and real-world settings, smaller proportions of patients with genotype 3 hepatitis C virus (HCV) infection and cirrhosis have a sustained virologic response 12 weeks after treatment (SVR12) with the combination of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55a62f588ce135fa70681f93b7ac76e
http://repositori.upf.edu/bitstream/10230/37186/1/esteban-gas-effi.pdf
http://repositori.upf.edu/bitstream/10230/37186/1/esteban-gas-effi.pdf
Autor:
Beat Müllhaupt, Diana M. Brainard, Brian McNabb, Enoka Gonsalkorala, G. Mani Subramanian, Jean-François Dufour, Sarah Arterburn, Christina Sze Man Yip, María del Pilar Leal Londoño, Luis Castells, Douglas C. MacDonald, Gregory Camus, Kosh Agarwal, Hai Cheng Huang, Xavier Forns, John McNally
Publikováno v:
Clinical Hepatology.
Background Treatment with SOF/VEL for 12 weeks results in high sustained virologic response rates 12 weeks after treatment (SVR12) in genotype 1–6 HCV infected patients in clinical trials and real-world settings. The current study evaluated the saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a9c77ff6f204571db1dbde3cef19dd
https://doi.org/10.1136/gutjnl-2018-iddfabstracts.210
https://doi.org/10.1136/gutjnl-2018-iddfabstracts.210
Autor:
Lluis Castells, Luisa M. Stamm, Gregory Camus, Zoe Mariño, William Rosenberg, Xavier Forns, John McNally, Sarah Arterburn, Beat Müllhaupt, Diana M. Brainard, Brian McNabb, G. Mani Subramanian, Jean-François Dufour, Kosh Agarwal
Publikováno v:
Journal of hepatology. 69(3)
Background & Aims Sofosbuvir, an NS5B inhibitor, combined with velpatasvir, an NS5A inhibitor (SOF/VEL), produces high sustained virologic response rates 12 weeks after treatment (SVR12) in patients with genotype 1–6 HCV infection, and has no antic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb26bd60985ed20655071317e1d6e11
https://pubmed.ncbi.nlm.nih.gov/29886154
https://pubmed.ncbi.nlm.nih.gov/29886154
Autor:
James Brian McNabb
This timely study synthesizes past history with the major military events and dynamics of the 20th- and 21st-century Middle East, helping readers understand the region's present-and look into its future.The Middle East has been-and will continue to b
Autor:
Eric Vittinghoff, Dennis M. Black, Ann V. Schwartz, Elizabeth Barrett-Connor, Kristine E. Ensrud, Richard Eastell, Brian McNabb, Douglas C. Bauer
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:4094-4100
Context: Women stopping alendronate are commonly monitored with serial bone mineral density (BMD) measurements, yet no information exists on how frequently or for whom these measurements should be performed. Objective: The objective of the study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b6895cd699d795feb9f30830d44e09
https://doi.org/10.1210/jc.2014-1193
https://doi.org/10.1210/jc.2014-1193
Autor:
Juan Turnes, Brian McNabb, R. Esteban, Mani Subramanian, Antonio Rivero, José Luis Calleja Panero, Miguel A. Casado, Juan Manuel Pascasio, M.B. Ferret, L.E.M. Amado, Gulan Zhang, Rosa Maria Morillas, José A. Carrión, M. Rodríguez, Gregory Camus, L.M. Stamm, Juan A. Pineda, D.M. Brainard, R.J. Andrade, Sabela Lens
Publikováno v:
Journal of Hepatology. 68:S20-S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8631ed47418cf4c5719dc454fce51ee
https://doi.org/10.1016/s0168-8278(18)30260-5
https://doi.org/10.1016/s0168-8278(18)30260-5
Autor:
Brian McNabb, Kosh Agarwal, M.S. Sulkowski, Rajender Reddy, S.C. Gordon, A. Osinusi, E.J. Gane, Ira M. Jacobson, D.M. Brainard, Hadas Dvory-Sobol, Mani Subramanian, M. Bourlière, F. Chen, M.B. Ferret, S. Zeuzem, Alnoor Ramji
Publikováno v:
Journal of Hepatology. 68:S527-S528
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7745cde79f4a19a7448ca698f22b3a81
https://doi.org/10.1016/s0168-8278(18)31306-0
https://doi.org/10.1016/s0168-8278(18)31306-0